T 1818/18 (Dry powder inhalation drug products / GLAXOSMITHKLINE) of 07.10.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T181818.20211007
- Date of decision
- 7 October 2021
- Case number
- T 1818/18
- Petition for review of
- -
- Application number
- 11755043.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- DRY POWDER INHALATION DRUG PRODUCTS EXHIBITING MOISTURE CONTROL PROPERTIES AND METHODS OF ADMINISTERING THE SAME
- Applicant name
- GlaxoSmithKline Intellectual Property Development Limited
- Opponent name
- Oser, Andreas
Generics (U.K.) Limited
Teva UK Limited - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2)European Patent Convention Art 54(3)European Patent Convention Art 56European Patent Convention Art 83European Patent Convention R 111(2)Rules of procedure of the Boards of Appeal 2020 Art 011Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Substantial procedural violation - appealed decision reasoned (yes)
Late submitted material - admitted (partly)
Sufficiency of disclosure - (yes)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- G 0001/15
- Citing cases
- -
Order
For these reasons it is decided that:
The appeals are dismissed.